Skip to main content
. Author manuscript; available in PMC: 2014 Jan 1.
Published in final edited form as: Biochim Biophys Acta. 2013 Jan;1831(1):117–125. doi: 10.1016/j.bbalip.2012.08.020

Figure 9.

Figure 9

Effect of GRI (1 mg/kg administered intraperitoneally at +24 h postirradiation) on mortality from the acute hematopoietic radiation syndrome in C57BL6 mice exposed to ~6.6 Gy γ-radiation at a dose rate of ~320 cGy/min. GRI significantly increased mean survival time (p < 0.01) and decreased mortality in treated mice compared to the vehicle group. Fifty % of the animals in the GRI treated group (open squares) survived up to 20 days and 20% survived up to 31 days after γ-irradiation (~LD80/30) compared to the vehicle-treated group (open squares).

Kiss et al.